Immatics NV (Immatics NV) FCF Margin % : 438.31% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Immatics NV FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Immatics NV's Free Cash Flow for the three months ended in Dec. 2023 was $76.10 Mil. Immatics NV's Revenue for the three months ended in Dec. 2023 was $17.36 Mil. Therefore, Immatics NV's FCF Margin % for the quarter that ended in Dec. 2023 was 438.31%.

As of today, Immatics NV's current FCF Yield % is -1.11%.

The historical rank and industry rank for Immatics NV's FCF Margin % or its related term are showing as below:

IMTX' s FCF Margin % Range Over the Past 10 Years
Min: -282.27 Med: 15.39 Max: 535.18
Current: -21.13

During the past 6 years, the highest FCF Margin % of Immatics NV was 535.18%. The lowest was -282.27%. And the median was 15.39%.

IMTX's FCF Margin % is ranked better than
68.95% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs IMTX: -21.13

Immatics NV FCF Margin % Historical Data

The historical data trend for Immatics NV's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV FCF Margin % Chart

Immatics NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

372.55

-282.27

-260.06

54.34

-23.57

Immatics NV Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-90.46	-286.25	-78.02	-624.94	438.31

Competitive Comparison of Immatics NV's FCF Margin %

For the Biotechnology subindustry, Immatics NV's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immatics NV's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Immatics NV's FCF Margin % falls into.

Immatics NV FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Immatics NV's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-13.881	/	58.884
	=	-23.57 %

Immatics NV's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	76.1	/	17.362
	=	438.31 %

Immatics NV FCF Margin % Related Terms

Thank you for viewing the detailed overview of Immatics NV's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immatics NV (Immatics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4A3:Germany

Address

Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.immatics.com

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.